08:40 AM EDT, 04/20/2026 (MT Newswires) -- ABG Sundal Collier on Monday initiated its coverage of biopharmaceutical company Camurus (CAMX.ST) with a buy rating and a price target of 750 kronor.

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Ämnen i artikeln

Camurus

Senast

568,50

1 dag %

−1,81%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån